Sonia Martín‐Pérez

Hospital Nuestra Señora de Alarcos — Spain

Medicine · Health Sciences

11h-index469citations29works8.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

COVID-19 Clinical Research Studies(16), COVID-19 and healthcare impacts(14), SARS-CoV-2 and COVID-19 Research(12), Antifungal resistance and susceptibility(3), Acute Lymphoblastic Leukemia research(3)

Publications29 total

P-2271. Unraveling the Past: Analyzing the Effects of COVID-19 on Hematological Malignancy Patients - Observations from 2020 to 2022
Open Forum Infectious Diseases·2025Open Access
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: <scp>EPICOVIDEHA</scp>‐<scp>EPIFLUEHA</scp> Report
American Journal of Hematology·2024· 7 citedOpen Access
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection·2024Open Access
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry
Haematologica·2024· 7 citedOpen Access
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
EClinicalMedicine·2024· 29 citedOpen Access
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
Infection·2024· 9 citedOpen Access
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
Hematological Oncology·2023· 14 citedOpen Access
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey
Leukemia & lymphoma/Leukemia and lymphoma·2023· 9 citedOpen Access
Decoding the Historical TALE: COVID-19 Impact on Hematological Malignancy Patients - Insights from 2020 to 2022
Blood·2023Open Access
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
International Journal of Infectious Diseases·2023· 14 citedOpen Access
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
International Journal of Antimicrobial Agents·2023· 17 citedOpen Access
Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study
Mycopathologia·2023· 25 citedOpen Access
P1480: CLINICAL AND GENETIC STUDY OF HEREDITARY SPHEROCYTOSIS IN THE SPANISH POPULATION.
HemaSphere·2023Open Access
P1521: IMPROVED CLINICAL OUTCOME OF COVID-19 IN HAEMATOLOGIC MALIGNANCY PATIENTS RECEIVING A FOURTH DOSE OF ANTI-SARS-COV-2 VACCINE: AN EPICOVIDEHA REPORT
HemaSphere·2023Open Access
PB2586: PASSIVE PREEXPOSURE IMMUNIZATION BY TIXAGEVIMAB/CILGAVIMAB IN COVID 19 INFECTED HEMATOLOGICAL MALIGNANCY OF EPICOVIDHEA SURVEY
HemaSphere·2023Open Access
S292: NIRMATRELVIR/RITONAVIR IN COVID-19 PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: A REPORT FROMTHE EPICOVIDEHA REGISTRY
HemaSphere·2023Open Access
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
EClinicalMedicine·2023· 33 citedOpen Access
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
Journal of Hematology & Oncology·2023· 19 citedOpen Access
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
The Lancet Infectious Diseases·2023· 125 citedOpen Access
Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry
Therapeutic Advances in Hematology·2023· 8 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jon Salmanton‐García(28), Julio Dávila(27), Francesco Marchesi(24), Francesca Farina(24), Oliver A. Cornely(23), Andreas Glenthøj(23), Federico Itri(22), Ola Blennow(21), Caterina Buquicchio(21), Lucia Prezioso(21), Raúl Córdoba(21), Jens Van Praet(20), Yavuz M. Bilgin(20), Alberto López‐García(20), Martin Schönlein(20), Monia Marchetti(20), Laman Rahimli(19), Livio Pagano(19), Jaap A. van Doesum(19), Barbora Weinbergerová(19)